Table 2 Univariate and multivariate analyses for disease-free survival in women with ovarian non-serous carcinoma
DFSa | Eventsb | Univariate | Multivariate | |||
|---|---|---|---|---|---|---|
p | HR | CI 95% | p | |||
Age, y | ||||||
≤ 53 | 51.9% | 44/87 (50.6%) | ||||
> 53 | 26.7% | 61/92 (66.3%) | 0.025 | |||
Menopausal Status | ||||||
Premenopausal | 56.1% | 32/70 (45.7%) | 0.003 | |||
Postmenopausal | 27.7% | 73/109 (66.9%) | ||||
Histologic type | ||||||
Clear | 29.3% | 31/48 (64.6%) | 0.310 | |||
Müsinöz | 48.3% | 27/47 (53.8%) | ||||
Endometrioid | 41.8% | 28/52 (53.8%) | ||||
Mixt | 33.6% | 19/32 (59.3%) | ||||
Route of Spread | ||||||
Intraperitoneal | 37.6% | 43/72 (59.7%) | 0.002 | |||
Retroperitoneal | 66.4% | 14/35 (40%) | ||||
Intra+Retroperitoneal | 25.5% | 48/72 (66.6%) | ||||
Peritoneal cytology | ||||||
Positive | 38.1% | 37/61 (60.6%) | 0.717 | |||
Negative | 40.8% | 68/118 (57.6%) | ||||
Bilateralty | ||||||
Unilateral | 49.4% | 49/97 (50.5%) | 0.010 | |||
Bilateral | 26.8% | 56/82 (68.2%) | ||||
Tumor size(cm) | ||||||
< 10 | 53.4% | 21/45 (46.6%) | 0.321 | |||
≥ 10 | 63.3% | 16/48 (33.3%) | ||||
CA-125(IU/ml) | ||||||
< 250 | 38.4% | 55/88 (31.4%) | 0.720 | |||
≥ 250 | 39% | 47/84 (44.8%) | ||||
Ascites | ||||||
Yes | 40.6% | 41/79 (51.9%) | 0.131 | |||
No | 39% | 64/100 (64%) | ||||
LN involvement | ||||||
Yes | 39.9% | 62/107 (57.9%) | 0.761 | |||
No | 37.6% | 43/72 (59.7%) | ||||
Omental involvement | ||||||
Yes | 26.7% | 73/106 (68.8%) | < 0.001 | |||
No | 57.5% | 31/71 (43.6%) | ||||
Grade | ||||||
Grade 1-2 | 63% | 26/64 (40.6%) | < 0.001 | 2.3 | 1.421-3.929 | 0.001 |
Grade 3 | 24.4% | 48/67 (71.6%) | ||||
CRS | ||||||
Maximal | 83.1% | 9/51 (17.6%) | < 0.001 | 5.3 | 2.374-12.142 | < 0.001 |
Optimal | 23.3% | 96/128 (75%) | ||||